[in process]

Med Monatsschr Pharm. 2017 May;40(5):222-3.
[Article in German]
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications*
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / mortality
  • Dabigatran / therapeutic use*
  • Rivaroxaban / therapeutic use*

Substances

  • Anticoagulants
  • Rivaroxaban
  • Dabigatran